Skip to main content
TipRanks
Go Ultimate75% OFF

MapLight Therapeutics, Inc. (MPLT) Ratios

38 Followers

MapLight Therapeutics, Inc. Ratios

MPLT's free cash flow for Q3 2026 was $-35.69M. For the 2026 fiscal year, MPLT's free cash flow was decreased by $-12.00K and operating cash flow was $-35.68M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio20.017.205.692.54
Quick Ratio20.017.205.692.54
Cash Ratio2.882.405.432.20
Solvency Ratio-7.60-3.54-2.74-1.59
Operating Cash Flow Ratio-8.51-4.95-3.54-2.11
Short-Term Operating Cash Flow Coverage-155.04-101.30-105.06-76.37
Net Current Asset Value$ 303.53M$ 92.88M$ 63.48M$ 13.51M
Leverage Ratios
Debt-to-Assets Ratio0.010.050.060.16
Debt-to-Equity Ratio0.010.060.080.30
Debt-to-Capital Ratio0.010.050.080.23
Long-Term Debt-to-Capital Ratio0.000.000.000.00
Financial Leverage Ratio1.051.191.281.89
Debt Service Coverage Ratio-180.22-98.82-111.42-84.60
Interest Coverage Ratio0.000.000.000.00
Debt to Market Cap0.000.000.000.00
Interest Debt Per Share0.130.160.140.15
Net Debt to EBITDA0.250.411.340.73
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%
EBT Per EBIT95.31%93.53%97.25%96.07%
Return on Assets (ROA)-33.61%-56.66%-60.94%-76.20%
Return on Equity (ROE)-35.16%-67.35%-78.15%-143.82%
Return on Capital Employed (ROCE)-36.50%-68.55%-74.67%-116.62%
Return on Invested Capital (ROIC)-36.43%-68.11%-74.19%-115.12%
Return on Tangible Assets-33.61%-56.66%-60.94%-76.20%
Earnings Yield-20.83%-10.21%-7.33%-3.95%
Efficiency Ratios
Receivables Turnover0.000.000.000.00
Payables Turnover0.000.370.170.16
Inventory Turnover0.000.000.000.00
Fixed Asset Turnover0.000.000.000.00
Asset Turnover0.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.00
Cash Conversion Cycle0.00-995.55-2133.54-2286.02
Days of Sales Outstanding0.000.000.000.00
Days of Inventory Outstanding0.000.000.000.00
Days of Payables Outstanding0.00995.552133.542286.02
Operating Cycle0.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-3.14-1.90-1.26-0.64
Free Cash Flow Per Share-3.15-1.92-1.27-0.66
Dividend Paid and CapEx Coverage Ratio-292.04-102.36-112.57-35.63
Capital Expenditure Coverage Ratio-292.04-102.36-112.57-35.63
Operating Cash Flow Coverage Ratio-23.81-11.98-8.78-4.24
Operating Cash Flow to Sales Ratio0.000.000.000.00
Free Cash Flow Yield-17.92%-10.47%-6.91%-3.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-4.80-9.81-13.64-25.31
Price-to-Sales (P/S) Ratio0.000.000.000.00
Price-to-Book (P/B) Ratio1.696.6010.6636.41
Price-to-Free Cash Flow (P/FCF) Ratio-5.58-9.55-14.48-27.81
Price-to-Operating Cash Flow Ratio-5.60-9.64-14.61-28.59
Price-to-Earnings Growth (PEG) Ratio-0.05-0.25-0.160.00
Enterprise Value Multiple-4.56-9.47-12.44-25.08
Enterprise Value732.58M728.13M685.96M738.41M
EV to EBITDA-4.56-9.47-12.44-25.08
EV to Sales0.000.000.000.00
EV to Free Cash Flow-5.29-9.15-13.07-27.03
EV to Operating Cash Flow-5.30-9.24-13.19-27.78
Tangible Book Value Per Share10.412.781.720.50
Shareholders’ Equity Per Share10.412.781.720.50
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00
Revenue Per Share0.000.000.000.00
Net Income Per Share-3.66-1.87-1.34-0.72
Tax Burden1.001.001.001.00
Interest Burden1.001.001.001.00
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue0.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.00
Income Quality0.861.020.930.89

Currency in USD